AWM
CVS icon

Aevitas Wealth Management’s CVS Health CVS Stock Holding History

Aevitas Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.43M Buy
15,294
+1,690
+12% +$163K 0.84% 31
2022
Q3 		$1.3M Buy
13,604
+732
+6% +$72.5K 0.97% 29
2022
Q2 		$1.19M Buy
12,872
+29
+0.2% +$2.83K 0.81% 39
2022
Q1 		$1.3M Sell
12,843
-799
-6% -$83.9K 0.79% 37
2021
Q4 		$1.41M Buy
13,642
+1,126
+9% +$104K 0.84% 34
2021
Q3 		$1.06M Buy
12,516
+335
+3% +$28.1K 0.68% 40
2021
Q2 		$1.02M Buy
12,181
+137
+1% +$11.2K 0.65% 45
2021
Q1 		$906K Buy
12,044
+338
+3% +$24.6K 0.63% 45
2020
Q4 		$799K Buy
11,706
+1,595
+16% +$104K 0.58% 48
2020
Q3 		$591K Buy
10,111
+361
+4% +$22.5K 0.49% 56
2020
Q2 		$633K Buy
9,750
+1,544
+19% +$97.2K 0.58% 48
2020
Q1 		$487K Buy
8,206
+2,895
+55% +$193K 0.55% 56
2019
Q4 		$395K Sell
5,311
-47
-0.9% -$3.3K 0.37% 70
2019
Q3 		$338K Buy
5,358
+21
+0.4% +$1.24K 0.34% 79
2019
Q2 		$291K Buy
5,337
+221
+4% +$11.9K 0.29% 92
2019
Q1 		$275K Sell
5,116
-12
-0.2% -$741 0.24% 93
2018
Q4 		$336K Buy
5,128
+17
+0.3% +$1.27K 0.34% 72
2018
Q3 		$402K Buy
5,111
+614
+14% +$43.9K 0.36% 72
2018
Q2 		$289K Buy
4,497
+743
+20% +$49K 0.28% 82
2018
Q1 		$234K Buy
3,754
+12
+0.3% +$861 0.23% 94
2017
Q4 		$271K Buy
+3,742
New +$272K 0.26% 88

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aevitas Wealth Management's CVS Position: Q4 2022 in Review

Aevitas Wealth Management increased its CVS Health (CVS) stake by 12% in Q4 2022, buying an estimated $163K and bringing the position to 15,294 shares worth $1.43M. The position accounts for 0.84% of the portfolio, ranked #31.

Aevitas Wealth Management first reported a position in CVS in Q4 2017 and has held it in 21 quarters since. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Aevitas Wealth Management held 15,294 shares of CVS Health worth $1.43M as of Q4 2022.
  • Aevitas Wealth Management bought 1,690 CVS Health shares in Q4 2022, an estimated $163K.
  • CVS Health made up 0.84% of Aevitas Wealth Management's portfolio in Q4 2022, its #31 holding.
  • Aevitas Wealth Management first reported a position in CVS Health in Q4 2017 and has held it in 21 quarters since.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Aevitas Wealth Management's 13F filing for Q4 2022, filed 24 Jan 2023.